Barclays Starts Abbott Labs (ABT) at Overweight
Barclays analyst Matt Miksic initiates coverage on Abbott Labs (NYSE: ABT) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

